Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

NCT06359626 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: YHP2205
DRUG: YHR2401

Sponsor

Yuhan Corporation